Ally Pharma Options Private Limited

Ally Pharma Options Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24230MH2003PTC138511 Incorporated 02 January 2003 ROC Mumbai HQ Mumbai, Maharashtra, India
Merged Private Limited Company pharma
Data last updated
Revenue · FY 2015
₹39.79 Cr
▲ 37.22% YoY
EBITDA · FY 2015
*****
▲ 52.41% YoY
Net profit · FY 2015
*****
▼ 4.69% YoY
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.9 Cr
Issued & subscribed
Open charges
None
Satisfied ₹16.66 Cr
Company age
23 yrs
Est. 2003
Last financials
Mar 2015
Balance sheet date

About Ally Pharma Options Private Limited

Data last updated: 26 July 2025

Ally Pharma Options Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 02 January 2003.

Registered with ROC Mumbai under CIN U24230MH2003PTC138511.

Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.9 Cr. It was led by directors including Hemlata Madanlal Sakhala and Madanlal Mohanlal Sakhala.

Last AGM: 30 September 2015. Financial statements filed for year ended 31 March 2015. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2015, the company reported a revenue of ₹39.79 Cr, a growth of 37.22% compared to the previous year.

As per MCA filings, the company had satisfied charges of ₹16.66 Cr on record.

The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity.

Company Details of Ally Pharma Options Private Limited
CIN U24230MH2003PTC138511
Registration Number 138511
Incorporation Date 02 January 2003
ROC Mumbai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 September 2015
Date of Balance Sheet 31 March 2015
Key People
Mehul Madan Sakhala Whole-Time Director Hemlata Madanlal Sakhala Director Madanlal Mohanlal Sakhala Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    301 3Rd Floor Maxheal House Plot No. 169 Cst No. 1043 Bangur Nagar Goregaon (We, St), Mumbai, Maharashtra, India – 400090
  • Industry
    Pharma, Drug Formulation & Development
Company report
Ally Pharma Options Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ally Pharma Options Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ally Pharma Options Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Ally Pharma Options Private Limited

Ally Pharma Options Private Limited is audited by PHIRODIA BAFNA & ASSOCIATES for the financial year 2015. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
PHIRODIA BAFNA & ASSOCIATES blur-value blur-value blur-value

Board of Directors of Ally Pharma Options Private Limited

Ally Pharma Options Private Limited is currently managed by 3 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Hemlata Madanlal Sakhala
Also directs: Maxheal Laboratories Private Limited, Maxheal Pharmaceuticals (India) Limited
Director 14 Oct 2008 17 Years 8 Months As last reported
Madanlal Mohanlal Sakhala
Also directs: Maxheal Laboratories Private Limited, Maxheal Pharmaceuticals (India) Limited
Director 14 Oct 2008 17 Years 8 Months As last reported
Mehul Madan Sakhala
Also directs: Maxheal Laboratories Private Limited, Maxheal Pharmaceuticals (India) Limited
Whole-Time Director 14 Oct 2008 17 Years 8 Months As last reported
View all directors

Financials of Ally Pharma Options Private Limited FY 2015 filings available

Ally Pharma Options Private Limited reported revenue of ₹39.44 Cr (up 37.22% YoY) for FY 2015. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹39.44 Cr ▲ 37.22%
Profit
***** ▼ -4.69%
EBITDA
***** ▲ 52.41%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Ally Pharma Options Private Limited

The shareholding pattern for Ally Pharma Options Private Limited provides insights into the ownership structure and investor base of the company.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Ally Pharma Options Private Limited

Open charges
₹0
Satisfied charges
₹16.66 Cr
Breakdown by lending institutions
State Bank of India₹16.66 Cr
Latest charge details
DateLenderAmountStatus
20 Jan 2004 State Bank of India ₹6.1 Cr Satisfied
20 Jan 2004 State Bank of India ₹10.56 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Ally Pharma Options Private Limited

View historical data on people associated with Ally Pharma Options Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Ally Pharma Options Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Ally Pharma Options Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Ally Pharma Options Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Ally Pharma Options Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Ally Pharma Options Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Ally Pharma Options Private Limited

MSME Payment Delays by Ally Pharma Options Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Ally Pharma Options Private Limited

Subsidiaries & Group Companies of Ally Pharma Options Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ally Pharma Options Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Ally Pharma Options Private Limited

MCA Filings & Documents of Ally Pharma Options Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Ally Pharma Options Private Limited

Activity
30 Sep 2015
Ally Pharma Options Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
Charges
10 Jun 2015
A charge registered on 20 Jan 2004 via Charge ID 90146577 with State Bank Of India was fully satisfied on 10 Jun 2015.
Charges
10 Jun 2015
A charge registered on 20 Jan 2004 via Charge ID 80005732 with State Bank Of India was fully satisfied on 10 Jun 2015.
Activity
31 Mar 2015
Ally Pharma Options Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Mumbai.
Directors
14 Oct 2008
Hemlata Madanlal Sakhala was appointed as a Director on 14 Oct 2008 & has been associated with this company since 17 years 8 months.
Directors
14 Oct 2008
Madanlal Mohanlal Sakhala was appointed as a Director on 14 Oct 2008 & has been associated with this company since 17 years 8 months.

Frequently Asked Questions about Ally Pharma Options Private Limited

Ally Pharma Options Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Ally Pharma Options Private Limited is a amalgamated private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 02 January 2003 and is registered under CIN U24230MH2003PTC138511. The company was amalgamated as per MCA records and no longer exists as a legal entity.

Ally Pharma Options Private Limited was incorporated on 02 January 2003. Registered with ROC Mumbai.

The current directors of Ally Pharma Options Private Limited are:

The CIN (Corporate Identification Number) of Ally Pharma Options Private Limited is U24230MH2003PTC138511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Ally Pharma Options Private Limited is pharma. The company specifically operates in drug formulation and development.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available